For the Quarter Ending September 2025
North America
• In the United States, the Metamizole Sodium Price Index rose quarter-over-quarter in Q3 2025, influenced by rising production costs.
• Production costs increased due to a 2.6% year-over-year PPI rise in August 2025 and a 3.0% year-over-year CPI increase in September 2025.
• Demand for Metamizole Sodium was supported by a robust 5.42% year-over-year increase in retail sales in September 2025.
• The demand outlook faced headwinds from declining consumer confidence to 94.2 in September 2025.
• Raw material and finished goods inventories for chemical manufacturers did not build in Q3 2025, indicating tighter supply.
• Energy costs, including an overall year-over-year uptick in natural gas prices in Q3 2025, pressured production expenses.
• Increased pharmaceutical drug approvals in Q3 2025 provided a supportive market signal for Metamizole Sodium.
• Sluggish industrial production, with 0.1% year-over-year growth in September 2025, suggested weaker economic momentum.
Why did the price of Metamizole Sodium change in September 2025 in North America?
• Increased input and raw material costs for chemical manufacturers drove Metamizole Sodium price trends in Q3 2025.
• Rising energy and transportation expenses contributed to higher production costs for Metamizole Sodium during the quarter.
• Robust retail sales in September 2025 supported demand, influencing Metamizole Sodium price movements.
Europe
• Germany's Metamizole Sodium Price Index fell in Q3 2025, influenced by declining production costs.
• Metamizole Sodium production costs decreased in Q3 2025, as producer prices fell by 1.7% in September 2025.
• Benzene and methanol feedstock costs in Europe declined sharply in Q3 2025, reducing manufacturing expenses.
• Demand for pharmaceutical products in Germany strengthened in Q3 2025, driven by an aging population.
• Industrial production in Germany decreased by 1.0% in September 2025, indicating a weaker economic environment.
• Germany's Manufacturing Index was contracting in Q3 2025, suggesting a slowdown in overall economic activity.
• Retail sales rose by 0.2% in September 2025, with stable 6.3% unemployment and stabilizing consumer confidence.
• High operating costs, including a 2.4% CPI increase in September 2025, pressured the German chemical industry.
• Increased imports of pharmaceutical products into Germany in Q3 2025 intensified domestic market competition.
Why did the price of Metamizole Sodium change in September 2025 in Europe?
• Producer prices for industrial products decreased by 1.7% in September 2025, lowering Metamizole Sodium production costs.
• Benzene and methanol feedstock costs in Europe declined sharply in Q3 2025, reducing input expenses.
• Increased imports of pharmaceutical products into Germany in Q3 2025 intensified market competition.
APAC
• In China, the Metamizole Sodium Price Index fell quarter-over-quarter in Q3 2025, influenced by deflationary pressures in September 2025.
• Metamizole Sodium production costs remained stable as petrochemical feedstock, like benzene, held steady in Q3 2025.
• The Manufacturing Index contracted in September 2025, indicating a slowdown in industrial output impacting Metamizole Sodium demand.
• Metamizole Sodium demand faced headwinds from a 5.2% unemployment rate in September 2025, constraining consumer spending.
• Despite cautious consumers, retail sales grew 3.0% in September 2025, offering some support for Metamizole Sodium demand.
• Broad chemical industry oversupply through Q3 2025 contributed to downward pressure on Metamizole Sodium prices.
• Industrial production expanded 6.5% in September 2025, supporting supply chain stability for Metamizole Sodium raw materials.
• Consumer confidence at 89.6 in September 2025 indicated pessimism, reducing discretionary healthcare spending for Metamizole Sodium.
Why did the price of Metamizole Sodium change in September 2025 in APAC?
• Deflationary pressures (CPI -0.3% in September 2025) led to Metamizole Sodium price decline.
• Contracting Manufacturing Index in September 2025 signaled weak industrial demand, impacting Metamizole Sodium sales.
• Broad chemical oversupply in Q3 2025 and -2.3% PPI in September 2025 exerted downward price pressure.
